nivolumab/ipilimumab approved in europe for frontline unresectable malignant pleural mesothelioma
Published 3 years ago • 151 plays • Length 7:47Download video MP4
Download video MP3
Similar videos
-
7:47
nivolumab / ipilimumab approved in europe for frontline unresectable malignant pleural mesothelioma
-
7:47
nivolumab and ipilimumab approved in europe frontline unresectable malignant pleural mesothelioma
-
7:47
nivolumab & ipilimumab approved in europe for frontline unresectable malignant pleural mesothelioma
-
2:06
nivolumab plus ipilimumab vs chemotherapy in unresectable mesothelioma
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
10:02
unresectable nsclc - does checkmate 227's suggestion of an immunotherapy combination of yervoy and o
-
4:44
confirm trial: nivolumab in relapsed malignant mesothelioma
-
6:11
gracecast - does immunotherapy have activity in malignant pleural mesothelioma
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc
-
2:44
fdg-pet/ct vs. ct for tumor response to nivolumab plus ipilimumab in mesothelioma | oncotarget
-
2:06
checkmate-743 study in mesothelioma
-
0:43
dr. eng on the fda approval of nivolumab plus ipilimumab in crc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
2:12
atomic-meso: pegargiminase in malignant pleural mesothelioma
-
51:28
new perspectives in the treamtent of malignant pleural mesothelioma
-
6:19
emerging options for malignant pleural mesothelioma
-
1:42
real-world data for nivo in recurrent malignant pleural mesothelioma
-
1:24
dr. mcdermott on nivolumab plus ipilimumab in rcc